StreetInsider.com News Articles

Hydreight Technologies Announces Timing of Q2 2026 Financial Results and Investor Webcast Featuring Live Analyst Q&A

Thu, 27 Aug 2026 07:30:00 -0400

VANCOUVER, BC and LAS VEGAS, Aug. 27, 2026 /PRNewswire/ -- Hydreight Technologies Inc. ("Hydreight" or the "Company") (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6), a rapidly growing digital health platform and provider of compliant healthcare infrastructure across the United States, today announced that the Company will release its second quarter 2026 financial results after market close on Monday, August 31, 2026.

Hydreight Technologies Announces Timing of Q2 2026 Financial Results and Investor Webcast Featuring Live Analyst Q&A

Thu, 27 Aug 2026 07:30:00 -0400

Hydreight Technologies Announces Timing of Q2 2026 Financial Results and Investor Webcast Featuring Live Analyst Q&A

Thu, 27 Aug 2026 07:30:00 -0400

Hydreight Technologies Announces Timing of Q2 2026 Financial Results and Investor Webcast Featuring Live Analyst Q&A

Thu, 27 Aug 2026 07:30:00 -0400

Hydreight Technologies Announces Timing of Q2 2026 Financial Results and Investor Webcast Featuring Live Analyst Q&A

Thu, 27 Aug 2026 07:30:00 -0400

Hydreight Technologies Announces Timing of Q2 2026 Financial Results and Investor Webcast Featuring Live Analyst Q&A

Thu, 27 Aug 2026 07:30:00 -0400

Hydreight Technologies Announces Timing of Q2 2026 Financial Results and Investor Webcast Featuring Live Analyst Q&A

Thu, 27 Aug 2026 07:30:00 -0400

Hydreight Technologies Announces Timing of Q2 2026 Financial Results and Investor Webcast Featuring Live Analyst Q&A

Thu, 27 Aug 2026 07:30:00 -0400

Hydreight Technologies Announces Timing of Q2 2026 Financial Results and Investor Webcast Featuring Live Analyst Q&A

Thu, 27 Aug 2026 07:30:00 -0400

Hydreight Technologies Announces Timing of Q2 2026 Financial Results and Investor Webcast Featuring Live Analyst Q&A

Thu, 27 Aug 2026 07:30:00 -0400

Hydreight Technologies Announces Timing of Q2 2026 Financial Results and Investor Webcast Featuring Live Analyst Q&A

Thu, 27 Aug 2026 07:30:00 -0400

Hydreight Technologies Announces Timing of Q2 2026 Financial Results and Investor Webcast Featuring Live Analyst Q&A

Thu, 27 Aug 2026 07:30:00 -0400

Hydreight Technologies Announces Timing of Q2 2026 Financial Results and Investor Webcast Featuring Live Analyst Q&A

Thu, 27 Aug 2026 07:30:00 -0400

Hydreight Technologies Announces Timing of Q2 2026 Financial Results and Investor Webcast Featuring Live Analyst Q&A

Thu, 27 Aug 2026 07:30:00 -0400

Hydreight Technologies Announces Timing of Q2 2026 Financial Results and Investor Webcast Featuring Live Analyst Q&A

Thu, 27 Aug 2026 07:30:00 -0400

Hydreight Technologies Announces Timing of Q2 2026 Financial Results and Investor Webcast Featuring Live Analyst Q&A

Thu, 27 Aug 2026 07:30:00 -0400

Victory Square Provides Update on Hydreight and Healthcare Investments Following FDA Advisory Committee Recommendations on Peptide-Related Bulk Drug Substances

Wed, 29 Jul 2026 08:00:00 -0400

VANCOUVER, BC, July 29, 2026 /PRNewswire/ -- Victory Square Technologies Inc. ("Victory Square", "VST" or the "Company") (CSE: VST) (OTCQX: VSQTF) (FWB: 6F6) is providing shareholders with an update following today's news release issued by Hydreight Technologies Inc. ("Hydreight") regarding the recommendations of the U.S. Food and Drug Administration ("FDA") Pharmacy Compounding Advisory Committee ("PCAC") relating to certain peptide-related bulk drug substances.

Victory Square Provides Update on Hydreight and Healthcare Investments Following FDA Advisory Committee Recommendations on Peptide-Related Bulk Drug Substances

Wed, 29 Jul 2026 08:00:00 -0400

Victory Square Provides Update on Hydreight and Healthcare Investments Following FDA Advisory Committee Recommendations on Peptide-Related Bulk Drug Substances

Wed, 29 Jul 2026 08:00:00 -0400

Victory Square Provides Update on Hydreight and Healthcare Investments Following FDA Advisory Committee Recommendations on Peptide-Related Bulk Drug Substances

Wed, 29 Jul 2026 08:00:00 -0400

Victory Square Provides Update on Hydreight and Healthcare Investments Following FDA Advisory Committee Recommendations on Peptide-Related Bulk Drug Substances

Wed, 29 Jul 2026 08:00:00 -0400

Victory Square Provides Update on Hydreight and Healthcare Investments Following FDA Advisory Committee Recommendations on Peptide-Related Bulk Drug Substances

Wed, 29 Jul 2026 08:00:00 -0400

Victory Square Provides Update on Hydreight and Healthcare Investments Following FDA Advisory Committee Recommendations on Peptide-Related Bulk Drug Substances

Wed, 29 Jul 2026 08:00:00 -0400

Victory Square Provides Update on Hydreight and Healthcare Investments Following FDA Advisory Committee Recommendations on Peptide-Related Bulk Drug Substances

Wed, 29 Jul 2026 08:00:00 -0400

Victory Square Provides Update on Hydreight and Healthcare Investments Following FDA Advisory Committee Recommendations on Peptide-Related Bulk Drug Substances

Wed, 29 Jul 2026 08:00:00 -0400